{"id":369209,"title":"Notice: Guidance document updates to reflect new fees and policies for April 1, 2020  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T08:48:41.843000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/funding-fees/notice-updated-guidance-documents-new-fees-policies.html","snippet":"Notice: Guidance document updates to reflect new fees and policies for April 1, 2020 Date: March 16, 2020 In 2017 Health Canada began engaging stakeholders to revise fees and policies for regulatory activities related to human drugs, veterinary drugs, and medical devices. These…","rawSnapshotUrl":"/api/snapshots/raw/369209","browseUrl":"https://replay.healtharchive.ca/job-6/20260411084841/https://www.canada.ca/en/health-canada/services/drugs-health-products/funding-fees/notice-updated-guidance-documents-new-fees-policies.html#ha_snapshot=369209","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}